The Gynaecology Drugs Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Increasing development and approval of new drugs
High prevalence of gynecological diseases have urged number of companies to conduct extensive R&D activities for novel therapies. These new approvals help to enhance a competitive environment for novel therapies and thus drive market adoption. For instance, in Dec 2022, FDA approved Brexafemme manufactured by Scynexis for decreasing the recurrence of vulvovaginal candidiasis (RVVC) or chronic yeast infections. In Nov 2022, ELAHERE, manufactured by ImmunoGen, received FDA approval that is used in adults for FRα-positive, platinum-resistant epithelial ovarian, fallopian tube, and primary peritoneal cancer treatment.
What Questions Should You Ask before Buying a Market Research Report?
• How is the Gynaecology Drugs market evolving?
• What is driving and restraining the Gynaecology Drugs market?
• How will each Gynaecology Drugs submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each Gynaecology Drugs submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading Gynaecology Drugs markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the Gynaecology Drugs projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of Gynaecology Drugs projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the Gynaecology Drugs market?
• Where is the Gynaecology Drugs market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the Gynaecology Drugs market today, and over the next 10 years:
• Our 340-page report provides 166 tables and 293 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the Gynaecology Drugs market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Gynaecology Drugs prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Disease
• Gynaecology Cancers
• Contraception
• Female Infertility
• Menopausal Disorder
• Polycystic Ovary Syndrome
• Gynaecology Infections
• Endometriosis
• Other Diseases
Therapeutics
• Non-hormonal Therapies
– Anti-Infective Agents
– Antineoplastic Agents
– Anti-inflammatory Agents
– Other Non-hormonal Therapies
• Hormonal Therapies
– Estrogen Therapy
– Progestin Therapy
– Combination Therapy
– Thyroid Replacement Therapy
– Parathyroid Hormone Therapy
– Other Hormonal Therapies
Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Type
• Generics
• Branded
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 20 leading national markets:
North America
• U.S.
• Canada
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
• Rest of Latin America
MEA
• GCC
• South Africa
• Rest of MEA
Need industry data? Please contact us today.
The report also includes profiles and for some of the leading companies in the Gynaecology Drugs Market, 2023 to 2033, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• AbbVie
• Amgen
• AstraZeneca
• Bayer Pharmaceuticals
• Eli Lilly and Company
• GSK
• Janssen Pharma (Part of Johnson & Johnson)
• Merck
• Pfizer
• Roche
Overall world revenue for Gynaecology Drugs Market, 2023 to 2033 in terms of value the market will surpass US$43,561 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Gynaecology Drugs Market, 2023 to 2033 report help you?
In summary, our 340+ page report provides you with the following knowledge:
• Revenue forecasts to 2033 for Gynaecology Drugs Market, 2023 to 2033, with forecasts for disease, therapeutics, distribution channel, and type, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2033 for five regional and 20 key national markets – See forecasts for the Gynaecology Drugs Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 10 of the major companies involved in the Gynaecology Drugs Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Gynaecology Drugs Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Gynaecology Drugs Market Report 2023-2033: Forecasts by Disease (Gynaecology Cancers, Contraception, Female Infertility, Menopausal Disorders, Polycystic Ovary Syndrome (PCOS), Gynaecology Infections, Endometriosis, Other), by Therapeutics (Non-hormonal Therapies, Hormonal Therapies), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Type (Generic, Branded) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com
1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Gynaecology Drugs Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
2.1 Geographical Snapshot: Global Gynaecology Drugs Market
2.2 Disease Segment: Market Attractiveness Index
2.3 Therapeutics Segment: Market Attractiveness Index
2.4 Distribution Channel Segment: Market Attractiveness Index
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.2 Market Restraining Factors
3.2.3 Market Opportunities
3.2.4 Challenges
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Supplier Power
3.4.2 Buyer Power
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
4 Global Gynaecology Drugs Market Analysis by Disease
4.1 Key Findings
4.2 Disease Segment Growth Prospects
4.3 Global Gynaecology Drugs Market Size Estimation and Forecast by Disease
4.4 Gynaecology Cancers
4.4.1 Gynaecology Cancers Market Forecast by Region, 2023-2033 (US$ Mn)
4.4.2 Gynaecology Cancers Market Share by Region, 2023-2033 (%)
4.5 Contraception
4.5.1 Contraception Market Forecast by Region, 2023-2033 (US$ Mn)
4.5.2 Contraception Market Share by Region, 2023-2033 (%)
4.6 Female Infertility
4.6.1 Female Infertility Market Forecast by Region, 2023-2033 (US$ Mn)
4.6.2 Female Infertility Market Share by Region, 2023-2033 (%)
4.7 Menopausal Disorders
4.7.1 Menopausal Disorders Market Forecast by Region, 2023-2033 (US$ Mn)
4.7.2 Menopausal Disorders Market Share by Region, 2023-2033 (%)
4.8 Polycystic Ovary Syndrome
4.8.1 Polycystic Ovary Syndrome Market Forecast by Region, 2023-2033 (US$ Mn)
4.8.2 Polycystic Ovary Syndrome Market Share by Region, 2023-2033 (%)
4.9 Gynaecology Infections
4.9.1 Gynaecology Infections Market Forecast by Region, 2023-2033 (US$ Mn)
4.9.2 Gynaecology Infections Market Share by Region, 2023-2033 (%)
4.10 Endometriosis
4.10.1 Endometriosis Market Forecast by Region, 2023-2033 (US$ Mn)
4.10.2 Endometriosis Market Share by Region, 2023-2033 (%)
4.11 Other diseases
4.11.1 Other Diseases Market Forecast by Region, 2023-2033 (US$ Mn)
4.11.2 Other Disease Market Share by Region, 2023-2033 (%)
5 Global Gynaecology Drugs Market Analysis by Therapeutics
5.1 Key Findings
5.2 Therapeutics Segment Growth Prospects
5.3 Global Gynaecology Drugs Market Size Estimation and Forecast by Therapeutics
5.4 Global Gynaecology Drugs Market Share by Therapeutics, 2023 & 2033
5.5 Non-hormonal Therapies
5.5.1 Non-hormonal therapies Market Forecast by Region, 2023-2033 (US$ Mn)
5.5.2 Non-hormonal therapies Market Share by Region, 2023-2033 (%)
5.5.3 Non-hormonal therapies Market Forecast by Type, 2023-2033 (US$ Mn)
5.5.4 Non-hormonal therapies Market Share by Type, 2023-2033 (%)
5.5.4.1 Anti-Infective Agents
5.5.4.4 Antineoplastic Agents
5.5.4.7 Anti-inflammatory Agents
5.5.4.10 Other Non-hormonal Therapies
5.6 Hormonal Therapies
5.6.1 Hormonal Therapies Market Forecast by Region, 2023-2033 (US$ Mn)
5.6.2 Hormonal Therapies Market Share by Region, 2023-2033 (%)
5.6.3 Hormonal Therapies Market Forecast by Type, 2023-2033 (US$ Mn)
5.6.4 Hormonal Therapies Market Share by Type, 2023-2033 (%)
5.6.4.1 Estrogen Therapy
5.6.4.4 Progestin Therapy
5.6.4.7 Combination Therapy
5.6.4.10 Thyroid Replacement Therapy
5.6.4.13 Parathyroid Hormone Therapy
5.6.4.16 Other Hormonal Therapies
6 Global Gynaecology Drugs Market Analysis by Distribution Channel
6.1 Key Findings
6.2 Distribution Channel Segment Growth Prospects
6.3 Global Gynaecology Drugs Market Size Estimation and Forecast by Distribution Channel
6.4 Global Gynaecology Drugs Market Share by Distribution Channel, 2023 & 2033
6.5 Hospital Pharmacies
6.5.1 Hospital Pharmacies Market Forecast by Region, 2023-2033 (US$ Mn)
6.5.2 Hospital Pharmacies Market Share by Region, 2023-2033 (%)
6.6 Retail Pharmacies
6.6.1 Retail Pharmacies Market Forecast by Region, 2023-2033 (US$ Mn)
6.6.2 Retail Pharmacies Market Share by Region, 2023-2033 (%)
6.7 Online Pharmacies
6.7.1 Online Pharmacies Market Forecast by Region, 2023-2033 (US$ Mn)
6.7.2 Online Pharmacies Market Share by Region, 2023-2033 (%)
7 Global Gynaecology Drugs Market Analysis by Generics/Branded
7.1 Key Findings
7.2 Segment Growth Prospects, By Type
7.3 Global Gynaecology Drugs Market Share by Generics/Branded, 2023 & 2033
7.3.1 Gynaecology Drugs Market, By Generics
7.3.1.1 Generic Drugs Market Size Estimation and Forecast
7.3.2 Gynaecology Drugs Market, By Branded
7.3.2.1 Branded Drugs Market Size Estimation and Forecast
8 Global Gynaecology Drugs Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast
8.3 COVID-19 Impact Analysis: Recovery Scenarios (V, U, W, L)
9 North America Gynaecology Drugs Market Analysis
9.1 Key Findings
9.2 North America Gynaecology Drugs Market Attractiveness Index
9.3 North America Gynaecology Drugs Market by Country, 2023, 2028 & 2033 (US$ Mn)
9.4 North America Gynaecology Drugs Market Size Estimation and Forecast by Country
9.5 North America Gynaecology Drugs Market Size Estimation and Forecast by Disease
9.6 North America Gynaecology Drugs Market Size Estimation and Forecast by Therapeutics
9.7 North America Non-hormonal therapies Market Size Estimation and Forecast by Type
9.8 North America Hormonal Therapies Market Size Estimation and Forecast by Type
9.9 North America Gynaecology Drugs Market Size Estimation and Forecast by Distribution Channel
9.10 U.S.
9.10.1 U.S. Gynaecology Drugs Market by Disease
9.10.2 U.S. Gynaecology Drugs Market by Therapeutics
9.11 Canada
9.11.1 Canada Gynaecology Drugs Market by Disease
9.11.2 Canada Gynaecology Drugs Market by Therapeutics
10 Europe Gynaecology Drugs Market Analysis
10.1 Key Findings
10.2 Europe Gynaecology Drugs Market Attractiveness Index
10.3 Europe Gynaecology Drugs Market by Country, 2023, 2028 & 2033 (US$ Mn)
10.4 Europe Gynaecology Drugs Market Size Estimation and Forecast by Country
10.5 Europe Gynaecology Drugs Market Size Estimation and Forecast by Disease
10.6 Europe Gynaecology Drugs Market Size Estimation and Forecast by Therapeutics
10.7 Europe Non-hormonal therapies Market Size Estimation and Forecast by Type
10.8 Europe Hormonal Therapies Market Size Estimation and Forecast by Type
10.9 Europe Gynaecology Drugs Market Size Estimation and Forecast by Distribution Channel
10.10 Germany
10.10.1 Germany Gynaecology Drugs Market by Disease
10.10.2 Germany Gynaecology Drugs Market by Therapeutics
10.11 U.K.
10.11.1 U.K. Gynaecology Drugs Market by Disease
10.11.2 U.K. Gynaecology Drugs Market by Therapeutics
10.12 France
10.12.1 France Gynaecology Drugs Market by Disease
10.12.2 France Gynaecology Drugs Market by Therapeutics
10.13 Italy
10.13.1 Italy Gynaecology Drugs Market by Disease
10.13.2 Italy Gynaecology Drugs Market by Therapeutics
10.14 Spain
10.14.1 Spain Gynaecology Drugs Market by Disease
10.14.2 Spain Gynaecology Drugs Market by Therapeutics
10.15 Rest of Europe
10.15.1 Rest of Europe Gynaecology Drugs Market by Disease
10.15.2 Rest of Europe Gynaecology Drugs Market by Therapeutics
11 Asia Pacific Gynaecology Drugs Market Analysis
11.1 Key Findings
11.2 Asia Pacific Gynaecology Drugs Market Attractiveness Index
11.3 Asia Pacific Gynaecology Drugs Market by Country, 2023, 2028 & 2033 (US$ Mn)
11.4 Asia Pacific Gynaecology Drugs Market Size Estimation and Forecast by Country
11.5 Asia Pacific Gynaecology Drugs Market Size Estimation and Forecast by Disease
11.6 Asia-Pacific Gynaecology Drugs Market Size Estimation and Forecast by Therapeutics
11.7 Asia-Pacific Non-hormonal therapies Market Size Estimation and Forecast by Type
11.8 Asia-Pacific Hormonal Therapies Market Size Estimation and Forecast by Type
11.9 Asia Pacific Gynaecology Drugs Market Size Estimation and Forecast by Distribution Channel
11.10 Japan
11.10.1 Japan Gynaecology Drugs Market by Disease
11.10.2 Japan Gynaecology Drugs Market by Therapeutics
11.11 China
11.11.1 China Gynaecology Drugs Market by Disease
11.11.2 China Gynaecology Drugs Market by Therapeutics
11.12 India
11.12.1 India Gynaecology Drugs Market by Disease
11.12.2 India Gynaecology Drugs Market by Therapeutics
11.13 South Korea
11.13.1 South Korea Gynaecology Drugs Market by Disease
11.13.2 South Korea Gynaecology Drugs Market by Therapeutics
11.14 Australia
11.14.1 Australia Gynaecology Drugs Market by Disease
11.14.2 Australia Gynaecology Drugs Market by Therapeutics
11.15 Rest of APAC
11.15.1 Rest of APAC Gynaecology Drugs Market by Disease
11.15.2 Rest of APAC Gynaecology Drugs Market by Therapeutics
12 Latin America Gynaecology Drugs Market Analysis
12.1 Key Findings
12.2 Latin America Gynaecology Drugs Market Attractiveness Index
12.3 Latin America Gynaecology Drugs Market by Country, 2023, 2028 & 2033 (US$ Mn)
12.4 Latin America Gynaecology Drugs Market Size Estimation and Forecast by Country
12.5 Latin America Gynaecology Drugs Market Size Estimation and Forecast by Disease
12.6 Latin America Gynaecology Drugs Market Size Estimation and Forecast by Therapeutics
12.7 Latin America Non-hormonal therapies Market Size Estimation and Forecast by Type
12.8 Latin America Hormonal Therapies Market Size Estimation and Forecast by Type
12.9 Latin America Gynaecology Drugs Market Size Estimation and Forecast by Distribution Channel
12.10 Brazil
12.10.1 Brazil Gynaecology Drugs Market by Disease
12.10.2 Brazil Gynaecology Drugs Market by Therapeutics
12.11 Mexico
12.11.1 Mexico Gynaecology Drugs Market by Disease
12.11.2 Mexico Gynaecology Drugs Market by Therapeutics
12.12 Rest of Latin America
12.12.1 Rest of LATAM Gynaecology Drugs Market by Disease
12.12.2 Rest of LATAM Gynaecology Drugs Market by Therapeutics
13 MEA Gynaecology Drugs Market Analysis
13.1 Key Findings
13.2 MEA Gynaecology Drugs Market Attractiveness Index
13.3 MEA Gynaecology Drugs Market by Country, 2023, 2028 & 2033 (US$ Mn)
13.4 MEA Gynaecology Drugs Market Size Estimation and Forecast by Country
13.5 MEA Gynaecology Drugs Market Size Estimation and Forecast by Disease
13.6 MEA Gynaecology Drugs Market Size Estimation and Forecast by Therapeutics
13.7 MEA Non-hormonal therapies Market Size Estimation and Forecast by Type
13.8 MEA Hormonal Therapies Market Size Estimation and Forecast by Type
13.9 MEA Gynaecology Drugs Market Size Estimation and Forecast by Distribution Channel
13.10 South Africa
13.10.1 South Africa Gynaecology Drugs Market by Disease
13.10.2 South Africa Gynaecology Drugs Market by Therapeutics
13.11 GCC
13.11.1 GCC Gynaecology Drugs Market by Disease
13.11.2 GCC Gynaecology Drugs Market by Therapeutics
13.12 Rest of MEA
13.12.1 Rest of MEA Gynaecology Drugs Market by Disease
13.12.2 Rest of MEA Gynaecology Drugs Market by Therapeutics
14 Competitive Landscape
14.1 Company Share Analysis
14.2 Key Business Strategy Analysis
15 Company Profiles
15.1 Pfizer
15.1.1 Company Snapshot
15.1.2 Company Overview
15.1.3 Financial Analysis
15.1.4 Product Benchmarking
15.1.5 Strategic Outlook
15.2 Merck
15.2.1 Company Snapshot
15.2.2 Company Overview
15.2.3 Financial Analysis
15.2.4 Product Benchmarking
15.2.5 Strategic Outlook
15.3 GSK
15.3.1 Company Snapshot
15.3.2 Company Overview
15.3.3 Financial Analysis
15.3.4 Product Benchmarking
15.3.5 Strategic Outlook
15.4 AbbVie
15.4.1 Company Snapshot
15.4.2 Company Overview
15.4.3 Financial Analysis
15.4.4 Product Benchmarking
15.4.5 Strategic Outlook
15.5 Roche
15.5.1 Company Snapshot
15.5.2 Company Overview
15.5.3 Financial Analysis
15.5.4 Product Benchmarking
15.5.5 Strategic Outlook
15.6 Bayer Pharmaceuticals
15.6.1 Company Snapshot
15.6.2 Company Overview
15.6.3 Financial Analysis
15.6.4 Product Benchmarking
15.6.5 Strategic Outlook
15.7 Eli Lilly and Company
15.7.1 Company Snapshot
15.7.2 Company Overview
15.7.3 Financial Analysis
15.7.4 Product Benchmarking
15.7.5 Strategic Outlook
15.8 Janssen Pharma (subsidiary of Johnson and Johnson)
15.8.1 Company Snapshot
15.8.2 Company Overview
15.8.3 Financial Analysis
15.8.4 Product Benchmarking
15.8.5 Strategic Outlook
15.9 AstraZeneca
15.9.1 Company Snapshot
15.9.2 Company Overview
15.9.3 Financial Analysis
15.9.4 Product Benchmarking
15.9.5 Strategic Outlook
15.10 Amgen
15.10.1 Company Snapshot
15.10.2 Company Overview
15.10.3 Financial Analysis
15.10.4 Product Benchmarking
15.10.5 Strategic Outlook
16 Conclusion and Recommendations
16.1 Final findings of report
16.2 Recommendations for Market Players
List of Tables
Table 1 Global Gynaecology Drugs Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
Table 2 Gynaecology Drugs Market, By Region, 2022-2033 (USD Mn, AGR %, CAGR %) (V-shaped Recovery)
Table 3 Gynaecology Drugs Market, By Region, 2022-2033 (USD Mn, AGR %, CAGR %) (U-shaped Recovery)
Table 4 Gynaecology Drugs Market, By Region, 2022-2033 (USD Mn, AGR %, CAGR %) (W-shaped Recovery)
Table 5 Gynaecology Drugs Market, By Region, 2022-2033 (USD Mn, AGR %, CAGR %) (L-shaped Recovery)
Table 6 Gynaecology Drugs Disease Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 7 Approved Gynaecology cancer treatments
Table 8 Gynaecology Cancers Market, by Region, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 9 Contraception Market, by Region, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 10 Female Infertility Market, by Region, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 11 Menopausal Disorder Market, by Region, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 12 Polycystic Ovary Syndrome Market, by Region, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 13 Gynaecology Infections Market, by Region, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 14 Endometriosis Market, by Region, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 15 Other Indications Market, by Region, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 16 Gynaecology Drugs Therapeutics Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 17 Non-hormonal therapies Market, by Region, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 18 Gynaecology Non-hormonal therapy Market, By Type 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 19 Anti-Infective Agents Market, by Region, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 20 Antineoplastic Agents Market, by Region, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 21 Anti-inflammatory Agents Market, by Region, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 22 Other Non-hormonal therapies Market, by Region, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 23 Hormonal therapies Market, by Region, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 24 Gynaecology Hormonal therapy Market, By type 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 25 Estrogen Therapy Market, by Region, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 26 Progestin Therapy Market, by Region, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 27 Combination Therapy Market, by Region, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 28 Thyroid Replacement Therapy Market, by Region, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 29 Parathyroid Hormone Therapy Market, by Region, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 30 Other Hormonal therapies Market, by Region, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 31 Gynaecology Drugs Distribution Channel Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 32 Hospital Pharmacies Market, by Region, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 33 Retail Pharmacies Market, by Region, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 34 Online Pharmacies Market, by Region, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 35 Generics Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 36 Branded Type Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 37 Gynaecology Drugs Market, By Region, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 38 Gynaecology Drugs Market, By Region, 2022-2033 (USD Mn, AGR %, CAGR %) (V-shaped Recovery)
Table 39 Gynaecology Drugs Market, By Region, 2022-2033 (USD Mn, AGR %, CAGR %) (U-shaped Recovery)
Table 40 Gynaecology Drugs Market, By Region, 2022-2033 (USD Mn, AGR %, CAGR %) (W-shaped Recovery)
Table 41 Gynaecology Drugs Market, By Region, 2022-2033 (USD Mn, AGR %, CAGR %) (L-shaped Recovery)
Table 42 North America Gynaecology Drugs Market, By Country, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 43 North America Gynaecology Drugs Disease Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 44 North America Gynaecology Drugs Therapeutics Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 45 North America Gynaecology Non-hormonal therapy Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 46 North America Gynaecology Hormonal therapy Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 47 North America Gynaecology Distribution Channel Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 48 US Gynaecology Drugs Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 49 US Gynaecology Drugs Disease Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 50 US Gynaecology Drugs Therapeutics Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 51 Canada Gynaecology Drugs Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 52 Canada Gynaecology Drugs Disease Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 53 Canada Gynaecology Drugs Therapeutics Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 54 Europe Gynaecology Drugs Market, By Country, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 55 Europe Gynaecology Drugs Disease Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 56 Europe Gynaecology Drugs Therapeutics Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 57 Europe Gynaecology Non-hormonal therapy Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 58 Europe Gynaecology Hormonal therapy Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 59 Europe Gynaecology Distribution Channel Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 60 Germany Gynaecology Drugs Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 61 Germany Gynaecology Drugs Disease Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 62 Germany Gynaecology Drugs Therapeutics Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 63 UK Gynaecology Drugs Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 64 UK Gynaecology Drugs Disease Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 65 UK Gynaecology Drugs Therapeutics Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 66 France Gynaecology Drugs Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 67 France Gynaecology Drugs Disease Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 68 France Gynaecology Drugs Therapeutics Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 69 Italy Gynaecology Drugs Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 70 Italy Gynaecology Drugs Disease Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 71 Italy Gynaecology Drugs Therapeutics Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 72 Spain Gynaecology Drugs Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 73 Spain Gynaecology Drugs Disease Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 74 Spain Gynaecology Drugs Therapeutics Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 75 Rest of Europe Gynaecology Drugs Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 76 Rest of Europe Gynaecology Drugs Disease Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 77 Rest of Europe Gynaecology Drugs Therapeutics Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 78 Asia Pacific Gynaecology Drugs Market, By Country, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 79 Asia Pacific Gynaecology Drugs Disease Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 80 Asia Pacific Gynaecology Drugs Therapeutics Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 81 Asia-Pacific Gynaecology Non-hormonal therapy Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 82 Asia-Pacific Gynaecology Hormonal therapy Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 83 Asia-Pacific Gynaecology Distribution Channel Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 84 Japan Gynaecology Drugs Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 85 Japan Gynaecology Drugs Disease Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 86 Japan Gynaecology Drugs Therapeutics Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 87 China Gynaecology Drugs Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 88 China Gynaecology Drugs Disease Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 89 China Gynaecology Drugs Therapeutics Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 90 India Gynaecology Drugs Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 91 India Gynaecology Drugs Disease Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 92 India Gynaecology Drugs Therapeutics Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 93 South Korea Gynaecology Drugs Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 94 South Korea Gynaecology Drugs Disease Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 95 South Korea Gynaecology Drugs Therapeutics Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 96 Australia Gynaecology Drugs Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 97 Australia Gynaecology Drugs Disease Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 98 Australia Gynaecology Drugs Therapeutics Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 99 Rest of Asia Pacific Gynaecology Drugs Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 100 Rest of Asia Pacific Gynaecology Drugs Disease Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 101 Rest of Asia Pacific Gynaecology Drugs Therapeutics Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 102 Latin America Gynaecology Drugs Market, By Country, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 103 Latin America Gynaecology Drugs Disease Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 104 Latin America Gynaecology Drugs Therapeutics Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 105 Latin America Gynaecology Non-hormonal therapy Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 106 Latin America Gynaecology Hormonal therapy Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 107 Latin America Gynaecology Distribution Channel Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 108 Brazil Gynaecology Drugs Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 109 Brazil Gynaecology Drugs Disease Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 110 Brazil Gynaecology Drugs Therapeutics Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 111 Mexico Gynaecology Drugs Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 112 Mexico Gynaecology Drugs Disease Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 113 Mexico Gynaecology Drugs Therapeutics Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 114 Rest of Latin America Gynaecology Drugs Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 115 Rest of LATAM Gynaecology Drugs Disease Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 116 Rest of LATAM Gynaecology Drugs Therapeutics Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 117 MEA Gynaecology Drugs Market, By Country, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 118 MEA Gynaecology Drugs Disease Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 119 MEA Gynaecology Drugs Therapeutics Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 120 MEA Gynaecology Non-hormonal therapy Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 121 MEA Gynaecology Hormonal therapy Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 122 MEA Gynaecology Distribution Channel Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 123 South Africa Gynaecology Drugs Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 124 South Africa Gynaecology Drugs Disease Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 125 South Africa Gynaecology Drugs Therapeutics Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 126 GCC Gynaecology Drugs Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 127 GCC Gynaecology Drugs Disease Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 128 GCC Gynaecology Drugs Therapeutics Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 129 Rest of MEA Gynaecology Drugs Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 130 Rest of MEA Gynaecology Drugs Disease Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 131 Rest of MEA Gynaecology Drugs Therapeutics Market, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 132 Key Business Strategies Adopted by Key Players in Global Gynaecology Drugs Market Details
Table 133 Pfizer: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 134 Pfizer: Product Benchmarking
Table 135 Pfizer Inc: Company Recent Developments
Table 136 Merck: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 137 Merck: Product Benchmarking
Table 138 Merck: Company Product Pipeline
Table 139 Merck: Company Recent Developments
Table 140 GSK: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 141 GSK: Product Benchmarking
Table 142 GlaxoSmithKline: Company Product Pipeline
Table 143 GlaxoSmithKline: Company Recent Developments
Table 144 AbbVie: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website)
Table 145 AbbVie: Product Benchmarking
Table 146 AbbVie Inc: Company Product Pipeline
Table 147 AbbVie Inc: Company Recent Developments
Table 148 Roche: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 149 Roche: Product Benchmarking
Table 150 Roche Inc: Company Product Pipeline
Table 151 Bayer Pharmaceuticals: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 152 Bayer Pharmaceuticals: Product Benchmarking
Table 153 Bayer Pharmaceuticals Inc: Company Product Pipeline
Table 154 Bayer Pharmaceuticals: Company Recent Developments
Table 155 Eli Lilly and Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 156 Eli Lilly and Company: Product Benchmarking
Table 157 Janssen Pharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 158 Janssen Pharma: Product Benchmarking
Table 159 AstraZeneca: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 160 AstraZeneca: Product Benchmarking
Table 161 AstraZeneca: Company Product Pipeline
Table 162 AstraZeneca: Strategic Outlook
Table 163 Amgen: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 164 Amgen: Product Benchmarking
Table 165 Amgen: Strategic Outlook
List of Figures
Figure 1 Global Gynaecology Drugs Market Segmentation
Figure 2 Global Gynaecology Drugs Market Forecast by Region: Market Attractiveness Index
Figure 3 Global Gynaecology Drugs Market by Disease: Market Attractiveness Index
Figure 4 Global Gynaecology Drugs Market by Therapeutics: Market Attractiveness Index
Figure 5 Global Gynaecology Drugs Market by Distribution Channel: Market Attractiveness Index
Figure 6 Global Gynaecology Drugs Market: Market Dynamics
Figure 7 Global COVID Impact Analysis: Gynaecology Drugs Market Recovery Scenarios
Figure 8 Global Gynaecology Drugs Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 9 Global Gynaecology Drugs Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 10 Global Gynaecology Drugs Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 11 Global Gynaecology Drugs Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 12 Global Gynaecology Drugs Market: Porter’s Five Forces Analysis
Figure 13 Global Gynaecology Drugs Market Forecast by Disease 2023 (Revenue, CAGR%)
Figure 14 Global Gynaecology Drugs Market Share Forecast by Disease, 2022, 2027, 2032 (%)
Figure 15 Global Gynaecology Drugs Market Forecast by Disease, 2023-2033 (US$ million, AGR %)
Figure 16 Gynaecology Cancers Market Forecast by Region, 2023-2033 (US$ million)
Figure 17 Gynaecology Cancers Market Share Forecast by Region, 2023-2033 (%)
Figure 18 Contraception Market Forecast by Region, 2023-2033 (US$ million)
Figure 19 Contraception Market Share Forecast by Region, 2023-2033 (%)
Figure 20 Female Infertility Market Forecast by Region, 2023-2033 (US$ million)
Figure 21 Female Infertility Market Share Forecast by Region, 2023-2033 (%)
Figure 22 Menopausal Disorders Market Forecast by Region, 2023-2033 (US$ million)
Figure 23 Menopausal Disorders Market Share Forecast by Region, 2023-2033 (%)
Figure 24 Polycystic Ovary Syndrome Market Forecast by Region, 2023-2033 (US$ million)
Figure 25 Polycystic Ovary Syndrome Market Share Forecast by Region, 2023-2033 (%)
Figure 26 Gynaecology Infections Market Forecast by Region, 2023-2033 (US$ million)
Figure 27 Gynaecology Infections Market Share Forecast by Region, 2023-2033 (%)
Figure 28 Endometriosis Market Forecast by Region, 2023-2033 (US$ million)
Figure 29 Endometriosis Market Share Forecast by Region, 2023-2033 (%)
Figure 30 Other Disease Market Forecast by Region, 2023-2033 (US$ million)
Figure 31 Other Disease Market Share Forecast by Region, 2023-2033 (%)
Figure 32 Global Gynaecology Drugs Market Forecast by Therapeutics 2023 (Revenue, CAGR%)
Figure 33 Global Gynaecology Drugs Market Forecast by Therapeutics, 2023-2033 (US$ million, AGR %)
Figure 34 Global Gynaecology Drugs Market Share Forecast by Therapeutics, 2023, 2033 (%)
Figure 35 Non-hormonal therapies Market Forecast by Region, 2023-2033 (US$ million)
Figure 36 Non-hormonal therapies Market Share Forecast by Region, 2023-2033 (%)
Figure 37 Non-hormonal therapies Market Forecast by Type, 2023-2033 (US$ million)
Figure 38 Non-hormonal therapies Market Share Forecast by Type, 2023-2033 (%)
Figure 39 Anti-Infective Agents Market Forecast by Region, 2023-2033 (US$ million)
Figure 40 Anti-Infective Agents Market Share Forecast by Region, 2023-2033 (%)
Figure 41 Antineoplastic Agents Market Forecast by Region, 2023-2033 (US$ million)
Figure 42 Antineoplastic Agents Market Share Forecast by Region, 2023-2033 (%)
Figure 43 Anti-inflammatory Agents Market Forecast by Region, 2023-2033 (US$ million)
Figure 44 Anti-inflammatory Agents Market Share Forecast by Region, 2023-2033 (%)
Figure 45 Other Non-hormonal Therapies Market Forecast by Region, 2023-2033 (US$ million)
Figure 46 Other Non-hormonal Therapies Market Share Forecast by Region, 2023-2033 (%)
Figure 47 Hormonal Therapies Market Forecast by Region, 2023-2033 (US$ million)
Figure 48 Hormonal Therapies Market Share Forecast by Region, 2023-2033 (%)
Figure 49 Hormonal Therapies Market Forecast by Region, 2023-2033 (US$ million)
Figure 50 Hormonal Therapies Market Share Forecast by Type, 2023-2033 (%)
Figure 51 Estrogen Therapy Market Forecast by Region, 2023-2033 (US$ million)
Figure 52 Estrogen Therapy Market Share Forecast by Region, 2023-2033 (%)
Figure 53 Progestin Therapy Market Forecast by Region, 2023-2033 (US$ million)
Figure 54 Progestin Therapy Market Share Forecast by Region, 2023-2033 (%)
Figure 55 Combination Therapy Market Forecast by Region, 2023-2033 (US$ million)
Figure 56 Combination Therapy Market Share Forecast by Region, 2023-2033 (%)
Figure 57 Thyroid Replacement Therapy Market Forecast by Region, 2023-2033 (US$ million)
Figure 58 Thyroid Replacement Therapy Market Share Forecast by Region, 2023-2033 (%)
Figure 59 Parathyroid Hormone Therapy Market Forecast by Region, 2023-2033 (US$ million)
Figure 60 Parathyroid Hormone Therapy Market Share Forecast by Region, 2023-2033 (%)
Figure 61 Other Hormonal Therapies Market Forecast by Region, 2023-2033 (US$ million)
Figure 62 Other Hormonal Therapies Market Share Forecast by Region, 2023-2033 (%)
Figure 63 Global Gynaecology Drugs Market Forecast by Distribution Channel 2023 (Revenue, CAGR%)
Figure 64 Global Gynaecology Drugs Market Forecast by Distribution Channel, 2023-2033 (US$ million, AGR %)
Figure 65 Global Gynaecology Drugs Market Share Forecast by Distribution Channel, 2023, 2033 (%)
Figure 66 Hospital Pharmacies Market Forecast by Region, 2023-2033 (US$ million)
Figure 67 Hospital Pharmacies Market Share Forecast by Region, 2023-2033 (%)
Figure 68 Retail Pharmacies Market Forecast by Region, 2023-2033 (US$ million)
Figure 69 Retail Pharmacies Market Share Forecast by Region, 2023-2033 (%)
Figure 70 Online Pharmacies Market Forecast by Region, 2023-2033 (US$ million)
Figure 71 Online Pharmacies Market Share Forecast by Region, 2023-2033 (%)
Figure 72 Global Gynaecology Drugs Market Forecast by Generics/Branded 2023 (Revenue, CAGR%)
Figure 73 Global Gynaecology Drugs Market Share Forecast by Generics/Branded, 2023, 2033 (%)
Figure 74 Global Gynaecology Drugs Market Forecast by Generics, 2023-2033 (US$ million, AGR %)
Figure 75 Global Gynaecology Drugs Market Forecast by Branded, 2023-2033 (US$ million, AGR %)
Figure 76 Global Gynaecology Drugs Market Forecast by Region 2023, 2028, 2033 (Revenue)
Figure 77 Global Gynaecology Drugs Market Share Forecast by Region 2023, 2033(%)
Figure 78 Global Gynaecology Drugs Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Figure 79 Global Gynaecology Drugs Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 80 Global Gynaecology Drugs Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 81 Global Gynaecology Drugs Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 82 Global Gynaecology Drugs Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 83 North America Gynaecology Drugs Market Attractiveness Index, 2023
Figure 84 North America Gynaecology Drugs Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 85 North America Gynaecology Drugs Market Forecast by Country, 2023-2033 (US$ million, AGR %)
Figure 86 North America Gynaecology Drugs Market Share Forecast by Country, 2023 & 2033 (%)
Figure 87 North America Gynaecology Drugs Market Forecast by Disease, 2023-2033 (US$ million, AGR %)
Figure 88 North America Gynaecology Drugs Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 89 North America Gynaecology Drugs Market Forecast by Distribution Channel, 2023-2033 (US$ million, AGR %)
Figure 90 North America Gynaecology Drugs Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 91 North America Gynaecology Drugs Market Forecast by Distribution Channel, 2023-2033 (US$ million, AGR %)
Figure 92 North America Non-hormonal therapies Market Share Forecast by Type, 2023 & 2033 (%)
Figure 93 North America Gynaecology Drugs Market Forecast by Distribution Channel, 2023-2033 (US$ million, AGR %)
Figure 94 North America Hormonal Therapies Market Share Forecast by Type, 2023 & 2033 (%)
Figure 95 North America Gynaecology Drugs Market Forecast by Distribution Channel, 2023-2033 (US$ million, AGR %)
Figure 96 North America Gynaecology Drugs Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 97 U.S. Gynaecology Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 98 U.S. Gynaecology Drugs Market Forecast by Disease, 2023-2033 (US$ million, AGR %)
Figure 99 U.S. Gynaecology Drugs Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 100 U.S. Gynaecology Drugs Market Forecast by Therapeutics, 2023-2033 (US$ million, AGR %)
Figure 101 U.S. Gynaecology Drugs Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 102 Canada Gynaecology Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 103 Canada Gynaecology Drugs Market Forecast by Disease, 2023-2033 (US$ million, AGR %)
Figure 104 Canada Gynaecology Drugs Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 105 Canada Gynaecology Drugs Market Forecast by Therapeutics, 2023-2033 (US$ million, AGR %)
Figure 106 Canada Gynaecology Drugs Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 107 Europe Gynaecology Drugs Market Attractiveness Index, 2023
Figure 108 Europe Gynaecology Drugs Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 109 Europe Gynaecology Drugs Market Forecast by Country, 2023-2033 (US$ million, AGR %)
Figure 110 Europe Gynaecology Drugs Market Share Forecast by Country, 2023 & 2033 (%)
Figure 111 Europe Gynaecology Drugs Market Forecast by Disease, 2023-2033 (US$ million, AGR %)
Figure 112 Europe Gynaecology Drugs Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 113 Europe Gynaecology Drugs Market Forecast by Therapeutics, 2023-2033 (US$ million, AGR %)
Figure 114 Europe Gynaecology Drugs Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 115 Europe Non-hormonal therapies Market Forecast by Type, 2023-2033 (US$ million, AGR %)
Figure 116 Europe Non-hormonal therapies Market Share Forecast by Type, 2023 & 2033 (%)
Figure 117 Europe Hormonal Therapies Market Forecast by Type, 2023-2033 (US$ million, AGR %)
Figure 118 Europe Hormonal Therapies Market Share Forecast by Type, 2023 & 2033 (%)
Figure 119 Europe Gynaecology Drugs Market Forecast by Distribution Channel, 2023-2033 (US$ million, AGR %)
Figure 120 Europe Gynaecology Drugs Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 121 Germany Gynaecology Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 122 Germany Gynaecology Drugs Market Forecast by Disease, 2023-2033 (US$ million, AGR %)
Figure 123 Germany Gynaecology Drugs Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 124 Germany Gynaecology Drugs Market Forecast by Therapeutics, 2023-2033 (US$ million, AGR %)
Figure 125 Germany Gynaecology Drugs Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 126 UK Gynaecology Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 127 U.K. Gynaecology Drugs Market Forecast by Disease, 2023-2033 (US$ million, AGR %)
Figure 128 U.K. Gynaecology Drugs Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 129 U.K. Gynaecology Drugs Market Forecast by Therapeutics, 2023-2033 (US$ million, AGR %)
Figure 130 U.K. Gynaecology Drugs Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 131 France Gynaecology Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 132 France Gynaecology Drugs Market Forecast by Disease, 2023-2033 (US$ million, AGR %)
Figure 133 France Gynaecology Drugs Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 134 France Gynaecology Drugs Market Forecast by Therapeutics, 2023-2033 (US$ million, AGR %)
Figure 135 France Gynaecology Drugs Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 136 Italy Gynaecology Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 137 Italy Gynaecology Drugs Market Forecast by Disease, 2023-2033 (US$ million, AGR %)
Figure 138 Italy Gynaecology Drugs Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 139 Italy Gynaecology Drugs Market Forecast by Therapeutics, 2023-2033 (US$ million, AGR %)
Figure 140 Italy Gynaecology Drugs Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 141 Spain Gynaecology Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 142 Spain Gynaecology Drugs Market Forecast by Disease, 2023-2033 (US$ million, AGR %)
Figure 143 Spain Gynaecology Drugs Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 144 Spain Gynaecology Drugs Market Forecast by Therapeutics, 2023-2033 (US$ million, AGR %)
Figure 145 Spain Gynaecology Drugs Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 146 Rest of Europe Gynaecology Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 147 Rest of Europe Gynaecology Drugs Market Forecast by Disease, 2023-2033 (US$ million, AGR %)
Figure 148 Rest of Europe Gynaecology Drugs Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 149 Rest of Europe Gynaecology Drugs Market Forecast by Therapeutics, 2023-2033 (US$ million, AGR %)
Figure 150 Rest of Europe Gynaecology Drugs Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 151 Asia Pacific Gynaecology Drugs Market Attractiveness Index, 2023
Figure 152 Asia Pacific Gynaecology Drugs Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 153 Asia Pacific Gynaecology Drugs Market Forecast by Country, 2023-2033 (US$ million, AGR %)
Figure 154 Asia Pacific Gynaecology Drugs Market Share Forecast by Country, 2023 & 2033 (%)
Figure 155 Asia Pacific Gynaecology Drugs Market Forecast by Disease, 2023-2033 (US$ million, AGR %)
Figure 156 Asia Pacific Gynaecology Drugs Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 157 Asia-Pacific Gynaecology Drugs Market Forecast by Therapeutics, 2023-2033 (US$ million, AGR %)
Figure 158 Asia-Pacific Gynaecology Drugs Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 159 Asia-Pacific Non-hormonal therapies Market Forecast by Type, 2023-2033 (US$ million, AGR %)
Figure 160 Asia-Pacific Non-hormonal therapies Market Share Forecast by Type, 2023 & 2033 (%)
Figure 161 Asia-Pacific Hormonal Therapies Market Forecast by Type, 2023-2033 (US$ million, AGR %)
Figure 162 Asia-Pacific Hormonal Therapies Market Share Forecast by Type, 2023 & 2033 (%)
Figure 163 Asia Pacific Gynaecology Drugs Market Forecast by Distribution Channel, 2023-2033 (US$ million, AGR %)
Figure 164 Asia Pacific Gynaecology Drugs Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 165 Japan Gynaecology Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 166 Japan Gynaecology Drugs Market Forecast by Disease, 2023-2033 (US$ million, AGR %)
Figure 167 Japan Gynaecology Drugs Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 168 Japan Gynaecology Drugs Market Forecast by Therapeutics, 2023-2033 (US$ million, AGR %)
Figure 169 Japan Gynaecology Drugs Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 170 China Gynaecology Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 171 China Gynaecology Drugs Market Forecast by Disease, 2023-2033 (US$ million, AGR %)
Figure 172 China Gynaecology Drugs Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 173 China Gynaecology Drugs Market Forecast by Therapeutics, 2023-2033 (US$ million, AGR %)
Figure 174 China Gynaecology Drugs Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 175 India Gynaecology Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 176 India Gynaecology Drugs Market Forecast by Disease, 2023-2033 (US$ million, AGR %)
Figure 177 India Gynaecology Drugs Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 178 India Gynaecology Drugs Market Forecast by Therapeutics, 2023-2033 (US$ million, AGR %)
Figure 179 India Gynaecology Drugs Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 180 South Korea Gynaecology Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 181 South Korea Gynaecology Drugs Market Forecast by Disease, 2023-2033 (US$ million, AGR %)
Figure 182 South Korea Gynaecology Drugs Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 183 South Korea Gynaecology Drugs Market Forecast by Therapeutics, 2023-2033 (US$ million, AGR %)
Figure 184 South Korea Gynaecology Drugs Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 185 Australia Gynaecology Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 186 Australia Gynaecology Drugs Market Forecast by Disease, 2023-2033 (US$ million, AGR %)
Figure 187 Australia Gynaecology Drugs Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 188 Australia Gynaecology Drugs Market Forecast by Therapeutics, 2023-2033 (US$ million, AGR %)
Figure 189 Australia Gynaecology Drugs Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 190 Rest of Asia Pacific Gynaecology Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 191 Rest of APAC Gynaecology Drugs Market Forecast by Disease, 2023-2033 (US$ million, AGR %)
Figure 192 Rest of APAC Gynaecology Drugs Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 193 Rest of APAC Gynaecology Drugs Market Forecast by Therapeutics, 2023-2033 (US$ million, AGR %)
Figure 194 Rest of APAC Gynaecology Drugs Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 195 Latin America Gynaecology Drugs Market Attractiveness Index, 2023
Figure 196 Latin America Gynaecology Drugs Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 197 Latin America Gynaecology Drugs Market Forecast by Country, 2023-2033 (US$ million, AGR %)
Figure 198 Latin America Gynaecology Drugs Market Share Forecast by Country, 2023 & 2033 (%)
Figure 199 Latin America Gynaecology Drugs Market Forecast by Disease, 2023-2033 (US$ million, AGR %)
Figure 200 Latin America Gynaecology Drugs Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 201 Latin America Gynaecology Drugs Market Forecast by Therapeutics, 2023-2033 (US$ million, AGR %)
Figure 202 Latin America Gynaecology Drugs Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 203 Latin America Non-hormonal therapies Market Forecast by Type, 2023-2033 (US$ million, AGR %)
Figure 204 Latin America Non-hormonal therapies Market Share Forecast by Type, 2023 & 2033 (%)
Figure 205 Latin America Hormonal Therapies Market Forecast by Type, 2023-2033 (US$ million, AGR %)
Figure 206 Latin America Hormonal Therapies Market Share Forecast by Type, 2023 & 2033 (%)
Figure 207 Latin America Gynaecology Drugs Market Forecast by Distribution Channel, 2023-2033 (US$ million, AGR %)
Figure 208 Latin America Gynaecology Drugs Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 209 Brazil Gynaecology Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 210 Brazil Gynaecology Drugs Market Forecast by Disease, 2023-2033 (US$ million, AGR %)
Figure 211 Brazil Gynaecology Drugs Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 212 Brazil Gynaecology Drugs Market Forecast by Therapeutics, 2023-2033 (US$ million, AGR %)
Figure 213 Brazil Gynaecology Drugs Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 214 Mexico Gynaecology Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 215 Mexico Gynaecology Drugs Market Forecast by Disease, 2023-2033 (US$ million, AGR %)
Figure 216 Mexico Gynaecology Drugs Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 217 Mexico Gynaecology Drugs Market Forecast by Therapeutics, 2023-2033 (US$ million, AGR %)
Figure 218 Mexico Gynaecology Drugs Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 219 Rest of LATAM Gynaecology Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 220 Rest of LATAM Gynaecology Drugs Market Forecast by Disease, 2023-2033 (US$ million, AGR %)
Figure 221 Rest of LATAM Gynaecology Drugs Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 222 Rest of LATAM Gynaecology Drugs Market Forecast by Therapeutics, 2023-2033 (US$ million, AGR %)
Figure 223 Rest of LATAM Gynaecology Drugs Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 224 MEA Gynaecology Drugs Market Attractiveness Index, 2023
Figure 225 MEA Gynaecology Drugs Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 226 MEA Gynaecology Drugs Market Forecast by Country, 2023-2033 (US$ million, AGR %)
Figure 227 MEA Gynaecology Drugs Market Share Forecast by Country, 2023 & 2033 (%)
Figure 228 MEA Gynaecology Drugs Market Forecast by Disease, 2023-2033 (US$ million, AGR %)
Figure 229 MEA Gynaecology Drugs Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 230 MEA Gynaecology Drugs Market Forecast by Therapeutics, 2023-2033 (US$ million, AGR %)
Figure 231 MEA Gynaecology Drugs Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 232 MEA Non-hormonal therapies Market Forecast by Type, 2023-2033 (US$ million, AGR %)
Figure 233 MEA Non-hormonal therapies Market Share Forecast by Type, 2023 & 2033 (%)
Figure 234 MEA Hormonal Therapies Market Forecast by Type, 2023-2033 (US$ million, AGR %)
Figure 235 MEA Hormonal Therapies Market Share Forecast by Type, 2023 & 2033 (%)
Figure 236 MEA Gynaecology Drugs Market Forecast by Distribution Channel, 2023-2033 (US$ million, AGR %)
Figure 237 MEA Gynaecology Drugs Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 238 South Africa Gynaecology Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 239 South Africa Gynaecology Drugs Market Forecast by Disease, 2023-2033 (US$ million, AGR %)
Figure 240 South Africa Gynaecology Drugs Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 241 South Africa Gynaecology Drugs Market Forecast by Therapeutics, 2023-2033 (US$ million, AGR %)
Figure 242 South Africa Gynaecology Drugs Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 243 GCC Gynaecology Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 244 GCC Gynaecology Drugs Market Forecast by Disease, 2023-2033 (US$ million, AGR %)
Figure 245 GCC Gynaecology Drugs Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 246 GCC Gynaecology Drugs Market Forecast by Therapeutics, 2023-2033 (US$ million, AGR %)
Figure 247 GCC Gynaecology Drugs Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 248 Rest of MEA Gynaecology Drugs Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 249 Rest of MEA Gynaecology Drugs Market Forecast by Disease, 2023-2033 (US$ million, AGR %)
Figure 250 Rest of MEA Gynaecology Drugs Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 251 Rest of MEA Gynaecology Drugs Market Forecast by Therapeutics, 2023-2033 (US$ million, AGR %)
Figure 252 Rest of MEA Gynaecology Drugs Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 253 Global Gynaecology Drugs Market: Company Ranking Analysis, 2021
Figure 254 Pfizer: Net Revenue, 2019-2021 (US$ million, AGR%)
Figure 255 Pfizer: Regional Market Shares, 2021
Figure 256 Pfizer: Gross Profit, 2019-2021 (US$ million, AGR%)
Figure 257 Pfizer: R&D, 2019-2021 (US$ million, AGR%)
Figure 258 Merck: Net Revenue, 2019-2021 (US$ million, AGR%)
Figure 259 Merck: Regional Market Shares, 2021
Figure 260 Merck: Income from Continuing Operations Before Taxes, 2019-2021 (US$ million, AGR%)
Figure 261 Merck: R&D, 2019-2021 (US$ million, AGR%)
Figure 262 GSK: Net Revenue, 2019-2021 (US$ million, AGR%)
Figure 263 GSK: Regional Market Shares, 2021
Figure 264 GSK: Operating Profit, 2019-2021 (US$ million, AGR%)
Figure 265 GSK: R&D, 2019-2021 (US$ million, AGR%)
Figure 266 AbbVie: Net Revenue, 2019-2021 (US$ million, AGR%)
Figure 267 AbbVie: Regional Market Shares, 2021
Figure 268 AbbVie: Operating Earnings, 2019-2021 (US$ million, AGR%)
Figure 269 AbbVie: R&D, 2019-2021 (US$ million, AGR %)
Figure 270 Roche: Net Revenue, 2019-2021 (US$ million, AGR%)
Figure 271 Roche: Regional Market Shares, 2021
Figure 272 Roche: Operating Profit, 2019-2021 (US$ million, AGR%)
Figure 273 Roche: R&D, 2019-2021 (US$ million, AGR %)
Figure 274 Bayer Pharmaceuticals: Net Revenue, 2019-2021 (US$ million, AGR%)
Figure 275 Bayer Pharmaceuticals: Regional Market Shares, 2021
Figure 276 Bayer Pharmaceuticals: EBITDA, 2019-2021 (US$ million, AGR%)
Figure 277 Bayer Pharmaceuticals: R&D, 2019-2021 (US$ million, AGR %)
Figure 278 Eli Lilly and Company: Net Revenue, 2019-2021 (US$ million, AGR%)
Figure 279 Eli Lilly and Company: Regional Market Shares, 2021
Figure 280 Eli Lilly and Company: Net Income, 2019-2021 (US$ million, AGR%)
Figure 281 Eli Lilly and Company: R&D, 2019-2021 (US$ million, AGR %)
Figure 282 Janssen Pharma: Net Revenue, 2019-2021 (US$ million, AGR%)
Figure 283 Janssen Pharma: Regional Market Shares, 2021
Figure 284 Janssen Pharma: Gross Profit, 2019-2021 (US$ million, AGR %)
Figure 285 Janssen Pharma: R&D, 2019-2021 (US$ million, AGR %)
Figure 286 AstraZeneca: Net Revenue, 2019-2021 (US$ million, AGR %)
Figure 287 AstraZeneca: Regional Market Shares, 2021
Figure 288 AstraZeneca: Operating Profit, 2019-2021 (US$ million, AGR %)
Figure 289 AstraZeneca: R&D, 2019-2021 (US$ million, AGR %)
Figure 290 Amgen: Net Revenue, 2019-2021 (US$ million, AGR %)
Figure 291 Amgen: Regional Market Shares, 2021
Figure 292 Amgen: Gross Profit, 2019-2021 (US$ million, AGR %)
Figure 293 Amgen: R&D, 2019-2021 (US$ million, AGR %)
List of Companies Profiled in the Report
AbbVie
Amgen
AstraZeneca
Bayer Pharmaceuticals
Eli Lilly and Company
GSK
Janssen Pharma (Part of Johnson & Johnson)
Merck
Pfizer
Roche
List of Other Companies Mentioned in the Report
Alkem
Astellas Pharma
ChemoCentryx, Inc.
Daré Bioscience, Inc.
Emcure
Ferring Pharmaceuticals
ImmunoGen
Lupin Pharmaceuticals
Mankind Pharma
Mithra Pharmaceuticals
Myovant Sciences
Neurocrine Biosciences, Inc.
SCYNEXIS
List of Associations Mentioned in the Report
European Medicines Agency (EMA)
European Pharmaceutical Market Research Association (EPhMRA)
Food and Drug Administration (FDA) [US]
Health Canada
National Development and Reform Commission (NDRC) [China]
National Health Services (NHS) [UK]
National Institute for Health and Care Excellence (NICE) [UK]
National Institute of Allergy and Infectious Diseases (NIAID) [US]
National Institutes of Health [US]
National Pharmaceutical Pricing Authority (NPPA) [China]
Pharmaceuticals and Medical Devices Agency (PMDA) [Japan]
Servicio Sanitario Nazionale (SSN) [US]
UK Medicines and Healthcare Products Regulatory Agency (MHRA)
United States District Court for the District of New Jersey
University of California, San Diego [US]
University of Michigan [US]
US Patent Office
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
